Please assess the completion status of the following clinical trial:

Trial Title: Lidocaine and Outpatient Gynecologic Laparoscopy

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Female patients undergoing outpatient laparoscopic gynecologic surgery~* American society of anesthesiologists class (ASA) Physical status (PS) I and II~* Age between 18 and 64 years~* Fluent in English~* Body mass index (BMI) less than 35~Exclusion Criteria:~* History of allergy to local anesthetics~* History of chronic opioid use~* Pregnant patients~* Body Mass Index (BMI) greater than 35~* History of electrocardiogram (EKG) abnormalities~* Hepatic Impairment~* History of congestive heart failure~* Electrocardiogram (EKG) abnormalities~* History of heart block (subject with history of heart block)~* Current use of anti-arrhythmic medications~Drop -Outs:~* Patient or surgeon request~* Conversion of the surgery from laparoscopic to open

- Gender: FEMALE
- Minimum Age: 18 Years
- Maximum Age: 64 Years
- Healthy Volunteers: f

Study Arms:
- Lidocaine (Type: ACTIVE_COMPARATOR): Lidocaine administration 1.5 mg/kg bolus followed by a 2 mg/kg/hr infusion via intravenous catheter
- Placebo (Type: PLACEBO_COMPARATOR): Placebo will receive the same volume of saline infusion.

Based on this trial design, predict the completion outcome and termination type (if applicable).